Home   >  
Others Pathway
  >  
Interleukin Related

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Interleukin Related

Chemical Structure Cat. No. Product Name CAS No.
Anakinra Chemical Structure
 BCP30242 Anakinra 143090-92-0
Anakinra is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein.
F-901318 Chemical Structure
 BCP25872 F-901318 1928707-56-5
F-901318, also known as Olorofim, is a DHODH inhibitor potentially for the treatment of invasive aspergillosis.
AX-024 Chemical Structure
 BCP30051 AX-024 1370544-73-2
AX-024 is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A.
AX-024 hydrochloride Chemical Structure
 BCP30050 AX-024 hydrochloride 1704801-24-0
AX-024 hydrochloride is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A.
Cyanidin Chloride Chemical Structure
 BCP24007 Cyanidin Chloride 528-58-5
Cyanidin Chloride is a blocker of the cytokine interleukin-17A binding to the IL-17RA subunit to alleviate inflammation in vivo.
Secukinumab Chemical Structure
 BCP26257 Secukinumab 875356-43-7
Secukinumab is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A.
RCGD-423 Chemical Structure
 BCP29631 RCGD-423 108237-91-8
RCGD-423 is a modulator of gp130 signalling.
Ustekinumab Chemical Structure
 BCP20868 Ustekinumab 815610-63-0
Ustekinumab is a human monoclonal antibody used to treat psoriasis.
YM 90709 Chemical Structure
 BCP17183 YM 90709 163769-88-8
YM-90709 is a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor.
GIT 27 Chemical Structure
 BCP09284 GIT 27 6501-72-0
Biological Activity Orally active immunomodulatory agent that primarily argets macrophages. Inhibits TNF-α secretion via interference of macrophage toll-like receptor (TLR) 4 and TLR 2/6 signaling pathway. Also reduces the secretion of pro-inflammatory cytokines IL1-β, IL-10 and IFN-γ. Antidiabetogenic; prevents IL-β and IFN-γ-induced pancreatic islet cell death in vitro.
123下一页共 21 条记录 1 / 3 页 
0086-15971444841